# A Research Study to Evaluate BLX-0871 in Healthy Adults

> **NCT07140081** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Biolexis Therapeutics** · enrollment: 76 (estimated)

## Conditions studied

- Normal Healthy Adults

## Interventions

- **DRUG:** BLX-0871
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07140081
- **Lead sponsor:** Biolexis Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-04
- **Final completion:** 2026-05
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140081, "A Research Study to Evaluate BLX-0871 in Healthy Adults". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07140081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*